Interactive Tool Harnesses Real-World Data to Visualize Burden of Disease in HCM and Advance Equitable Access to CareSOUTH SAN FRANCISCO, Calif., ...

Cash Position & Operating Runway: As of December 31, 2024, ARS Pharma had cash, cash equivalents, and short-term investments ...

Imagine receiving a diagnosis that changes your life in an instant: hypertrophic cardiomyopathy, a heart condition that can strike without warning, claiming thousands of lives annually .

Milestone Pharmaceuticals Inc.’s MIST share price has surged by 11.06%, which has investors questioning if this is right time to sell.

Despite having cardiovascular risk factors, asymptomatic aircraft pilots referred for medical screenings demonstrate favorable long-term outcomes and a low risk for major cardiac events.

Hypertrophic cardiomyopathy, also known as HCM or thick heart syndrome, is a genetic condition that causes your heart muscle ...

Keros Therapeutics' stock has plummeted over 70% due to safety issues in its phase 2 PAH study, halting all trial arms. Learn more about KROS stock here.

Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ: AVR, ASX: AVR) a global structural heart company committed to ...

Treatment with HU6 led to significant reductions in body fat and abdominal visceral fat while preserving skeletal muscle in patients with obesity-related heart failure with preserved ejection fraction ...

The following is a summary of “Predicting factors for unresolved premature ventricular complexes in healthy children,” ...

Credit: Mihiripix/Shutterstock. Cadrenal Therapeutics has entered a partnership with Abbott for the tecarfarin anticoagulation and haemocompatibility with left ventricular assist devices (TECH-LVAD) ...

Love was red-hot in the first half, hitting several deep 3-pointers to help stake Arizona to a 14-point halftime lead. He finished 7-of-15 from the field and 6-of-12 from the 3-point line.